Trial intelligence / Profile preview

Bepantol Derma Spray for Skin Recovery After Laser Depilation

NCT03853525Phase 4Completed

Sponsor
Bayer
Start
Feb 2019
Primary completion
Mar 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, open-label trial of dexpanthenol (2 arms), sponsored by Bayer. Primary endpoint: Transepidermal water loss up to 23 days. Started Feb 2019; status: completed.

02

Drugs

dexpanthenol

Beyond the preview

Go deeper on NCT03853525.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03853525.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call